Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.
about
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United StatesExtranodal NK/T-cell lymphoma, nasal type: a case report of 7-year natural course and review of literatureEpstein-Barr virus-associated lymphoid malignancies: the expanding spectrum of hematopoietic neoplasmsSystemic lymphoma arising from hydroa vacciniforme-like lymphoma: report of two cases with review of literaturePeripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfallsEpstein-Barr Virus: Diseases Linked to Infection and TransformationAnalysis of 142 Northern Chinese patients with peripheral T/NK-Cell lymphomas: subtype distribution, clinicopathologic features, and prognosis.Chronic active Epstein-Barr virus infection associated with hemophagocytic syndrome and extra-nodal natural killer/T-cell lymphoma in an 18-year-old girl: A case report.Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification.Assessment of immunological changes in Epstein-Barr virus co-infection in Egyptian chronic HCV patients.Selected topics on lymphoid lesions in the head and neck regions.Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts.Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targetsAge-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma.The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsImmunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infectionEpstein-Barr virus-positive T/NK-cell lymphoproliferative disordersEBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management.Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma.Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximabLong-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy.Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferationsEpstein-Barr virus associated T-cell lymphoproliferative disease misdiagnosed as ulcerative colitis: a case report.Basophil activation by mosquito extracts in patients with hypersensitivity to mosquito bites.Epidemiologic overview of malignant lymphoma.Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic TumorsHydroa vacciniforme-like lymphoma of an adult: a case report with review of the literature.Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood: Report of a case with review of the literatureThe 2016 revision of the World Health Organization classification of lymphoid neoplasms.Viral-associated lymphoid proliferations.An adult case of systemic Epstein-Barr virus-positive T/natural killer-cell lymphoproliferative disorder with good outcome.Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein-Barr virus-positive patients with chronic lymphocytic leukemiaEarly lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.Epstein-Barr virus: silent companion or causative agent of chronic liver disease?Diagnosis and management of natural killer-cell malignancies.Primary cutaneous hydroa vacciniforme-like lymphoma with indolent clinical course: report of two cases and review of literature.Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.Uncommon non-Hodgkin lymphomas of childhood: pathological diagnosis, clinical features and treatment approaches.Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells
P2860
Q24617384-3E3043E5-8CD9-4DFD-B76F-4363F8B69DD4Q26783458-797E5985-F187-48D7-810E-7A363382F930Q26824570-9B45F729-C1BF-446F-8049-B3E2A0B530F2Q26864758-DBF884D8-0586-4422-A35B-DA4614FDB799Q27004241-34DE7A93-B6E5-4B4C-A7E9-B0F28AF3291EQ28074586-090D1A38-C7D1-4F33-B719-9BB11A8D9026Q33402915-4E578A8F-37B2-4AFE-B6C6-A9B819092A09Q33672734-CA289CD6-C011-4BF3-A28E-3E721DC69BBCQ33925581-C8F13E8B-BB41-4708-8ADF-BDA87808BE3BQ34548411-53BE7B24-D850-459F-B02C-B9074C68D8B9Q34567773-6CD0C4AC-B0C6-41FA-A7E2-218AFB154279Q34677558-DEAFC18A-2BD6-45B3-8AE3-121406381A8FQ34898306-D3D44C5C-E1E8-441C-939C-C37E550356E3Q35001573-FC056AF2-7E57-4BF9-A72F-197A6F6DBE92Q35029409-D74D4F9D-FF36-46B6-94B8-F06C478AEAEDQ35034767-C407F481-16C9-453C-9F55-794C922AB675Q35040638-B852C136-3F82-4263-AAFD-C8D426B91A34Q35040644-17A1B0F3-5FAE-4F17-839F-3EAC395C35EDQ35067397-159AB5D8-1A87-41AF-BDDE-AB9FD9324D06Q35170230-BA54987F-3AD9-468E-9942-C4A2DC1EE83FQ35219963-942F5D3C-E7DC-4283-AEB6-ABEDC5BF7D36Q35232848-38AFA34C-4416-4E28-B1E2-F1E914290CBCQ36014523-89C53F59-103A-43CA-9E6C-AF97FF3295DCQ36016196-ED83DA78-DDB4-48A1-8D17-2DC334A44194Q36074055-65A90C74-C828-46AF-BD80-72FA374CEEC4Q36177642-926F9F0F-DF6F-4D73-97DF-5EE288A74A33Q36869449-B51A1703-905D-4665-AC15-8AB553475098Q36905293-81AA304D-3FFB-444D-A7F3-C2786DDD3D19Q36920426-71235269-1D96-4FB1-B7B1-BEB5B3048059Q36941309-CE2E6A10-1CE9-44DC-8118-4E41228A8091Q37277877-21BF6EB5-AE3F-47B8-AC8A-43FB4F849422Q37321119-81E7E711-0E70-490E-8659-E94C6ACC9900Q37352773-CBC0C8F2-2C20-4D5D-94BD-0A5AE2ECFDE8Q37784165-13FD76D6-4BC0-4B4D-843D-B308F5BB9C24Q37810280-82F44584-4EEF-497D-96F1-31E228E665B1Q38027141-57224320-E54A-42E3-BF30-3C024146EDEFQ38035410-700A8808-EFCE-4679-8EDC-9A3356EE0DDDQ38179491-B00325D9-5C6A-41D4-980B-74A53A32510EQ38410415-C115207F-EF7A-4150-9477-69967C86CF84Q38741546-9E6C25E5-A5D8-4A50-9203-C3AE88538AFA
P2860
Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Epstein-Barr virus-associated ...... l meeting, 8-9 September 2008.
@en
Epstein-Barr virus-associated ...... l meeting, 8-9 September 2008.
@nl
type
label
Epstein-Barr virus-associated ...... l meeting, 8-9 September 2008.
@en
Epstein-Barr virus-associated ...... l meeting, 8-9 September 2008.
@nl
prefLabel
Epstein-Barr virus-associated ...... l meeting, 8-9 September 2008.
@en
Epstein-Barr virus-associated ...... l meeting, 8-9 September 2008.
@nl
P2093
P2860
P356
P1433
P1476
Epstein-Barr virus-associated ...... l meeting, 8-9 September 2008.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDP064
P577
2009-06-10T00:00:00Z